Concurrently, S&P assigned its “A” long-term rating to Bozeman Health’s proposed $73.4 million series 2018 revenue bonds.
The downgrade is based on several factors, including Bozeman Health’s deteriorating operating performance, heavy debt burden and weaker annual debt service coverage. S&P favorably viewed Bozeman Health’s strong enterprise profile.
The outlook is stable.
More articles on healthcare finance:
UCLA Health to establish health sciences learning center with $20M gift
7 latest hospital credit downgrades
10 hospitals seeking RCM talent
